
Loading, please wait...

Loading, please wait...

The International Classification of Diseases (ICD-11) recently recognized Prolonged Grief Disorder as a distinct clinical entity. This condition involves persistent and pervasive longing for the deceased. Consequently, clinicians need better tools to understand its prevalence and risk factors. The MARBLES project addresses this need. By pooling data from 16,666 bereaved individuals across nine countries, this initiative builds a unified archive for bereavement research.
Preliminary analyses of the MARBLES archive reveal striking statistics. About 18.3% of participants met the criteria for probable Prolonged Grief Disorder under ICD-11 guidelines. Furthermore, the study highlights specific demographics. The mean age of participants was in their mid-40s, and roughly 70% were female. One in four individuals had lost a partner. Similarly, 25% experienced an unnatural loss, such as an accident or suicide. These findings suggest that certain types of loss significantly increase the risk of pathological grief.
Researchers designed the archive to be FAIR: Findable, Accessible, Interoperable, and Reusable. Currently, it includes data on posttraumatic stress and depression symptoms. Moreover, it tracks emotion regulation and sociodemographic characteristics. This evolving resource will eventually include underrepresented groups like migrants. Therefore, it provides a powerful platform for studying the pathogenesis of grief. Professionals can use this data to refine interventions and improve patient outcomes in mental health care.
According to ICD-11, the diagnosis requires persistent longing or preoccupation with the deceased. These symptoms must last for at least six months post-bereavement. Additionally, the grief must exceed social and cultural norms while causing significant impairment in daily functioning.
Preliminary research from the MARBLES project suggests that women and those who experience unnatural losses are at higher risk. Additionally, losing a life partner is a major risk factor identified in the current datasets. Mental health history and poor emotion regulation also play significant roles.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always seek the advice of a qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


The MARBLES project pools data from 16,666 bereaved individuals to improve the understanding and clinical management of Prolonged Grief Disorder....
3 months ago

A statewide active case-finding initiative in Rajasthan screened 2.28 million individuals and detected 280,000 tuberculosis cases, reflecting a 12% positivity rate. Targeted surveillance among high-risk groups underscores the critical need for rapid molecular diagnostics and integrated care under the NTEP framework.
Today

New research reveals how verbal sexual insistence and communication behaviors interact to influence dyadic sexual desire among young couples, providing vital insights for psychosexual assessment and relational therapy.
Today

An internal probe at AIIMS New Delhi into the death of a 15-year-old patient highlights the clinical dilemmas of uncorrectable congenital cardiac anomalies. This review examines surgical feasibility evaluations, conservative medical palliation, acute cyanotic crisis management, and institutional audit standards.
Today

A randomized clinical trial demonstrates that caudal catheter-guided epidural lysis of adhesions provides superior pain relief and functional restoration compared to transforaminal lysis in patients suffering from failed back surgery syndrome at the L5-S1 level.
Today

The ferroptosis-immunity axis represents a critical driver of diabetic kidney disease progression. This review explores iron-dependent lipid peroxidation, innate immune cross-talk, emerging candidate biomarkers, and promising targeted therapies to delay renal decline alongside standard glycemic control.
Today